Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.03B |
| Enterprise Value | 6.2B |
| P/E Ratio | 72.73 |
| PEG Ratio | -27.64 |
| Price/Sales Ratio | 4.41 |
| Price/Book Ratio | 2.99 |
| Enterprise/Revenue | 4.77 |
| Enterprise/EBITDA | 29.3 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.06 |
| Operating Margin | 0.08 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 671.05M |
| Revenue/Share | 6.06 |
| Gross Profit | 553.69M |
| EBITDA | 118.49M |
| Net Income | 42.06M |
| Diluted EPS | 0.35 |
Balance Sheet
| Total Cash | 22.88M |
| Total Cash/Share | 0.19 |
| Total Debt | 281.24M |
| Total Debt/Equity | 0.26 |
| Current Ratio | 1.19 |
| Book Value Per Share | 9.34 |
Price History
| 52-Week Change | -52.06 |
| 52-Week High | 73.4 |
| 52-Week Low | 26.29 |
| Moving Average 50 Days | 31.3 |
| Moving Average 200 Days | 38.02 |
Statistics
| Average Volume | 4.02M |
| Shares Outstanding | 120M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.1 |
| Trailing Annual Dividend Yield | 0.37 |
| Payout Ratio | 0.38 |
| Last Split Factor | 3:2 |
| Last Split Date | April 20, 2018 |
AD
